PMV Pharmaceuticals, Inc.·4

Aug 20, 4:38 PM ET

Kung Winston 4

4 · PMV Pharmaceuticals, Inc. · Filed Aug 20, 2021

Insider Transaction Report

Form 4
Period: 2021-08-19
Kung Winston
COO, CFO
Transactions
  • Exercise/Conversion

    Common Stock

    2021-08-19$3.22/sh+5,000$16,1006,600 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-08-195,000214,034 total
    Exercise: $3.22Exp: 2028-02-21Common Stock (5,000 underlying)
Holdings
  • Stock Option (right to buy)

    (indirect: See footnote)
    Exercise: $3.22Exp: 2028-02-21Common Stock (237,412 underlying)
    237,412
Footnotes (3)
  • [F1]The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant.
  • [F2]All of the shares subject to the option are vested and immediately exercisable.
  • [F3]The shares are held of record by the Winston Kung Irrevocable Family Trust for the benefit of the reporting person's immediate family.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION